Page 221 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 221
P0592 A CROSS-SECTIONAL STUDY ON INTRAHEPATIC ePOSTERS
P0593 CHOLESTASIS INDICATORS OF VIRAL HEPATITIS
P0594 PATIENTS
P0595 Jun Cheng*, Jiangbin Wang, Wenhong Zhang, Xingxiang Yang,
P0596 Yang Cao, China
P0597
PREDICTIVE MODEL OF HBSAG NEGATIVIZATION
IN INACTIVE HBSAG CHRONIC CARRIERS, MAINLY
CAUCASIAN
M. Luisa González-Diéguez*, Carmen A. Navascués, Gino Albines,
Mercedes Rodríguez, Valle Cadahía, María Varela, Ramón Pérez,
Manuel Rodríguez, Spain
CAN SERUM LEVEL OF HEPATITIS B SURFACE ANTIGEN
(HBSAG) DIFFERENTIATE HBSAG INACTIVE CARRIER
STATE FROM CHRONIC HEPATITIS B?
Maryam Keshvari*, Shahnaz Sali, Heidar Sharafi, Seyede Hoda Alavian,
Seyed Moayed Alavian, Faranak Etesam, Shima Salimi,
Muayad A. Merza, Iran
HIGH FREQUENCY OF ACTIVE HCV INFECTION AMONG
SEROPOSITIVES IN WEST AFRICA AND EVIDENCE FOR
MULTIPLE TRANSMISSION PATHWAYS
Jennifer Layden, Nallely Mora*, Rhichard O. Phillips, Shirley Owusi-
Ofori, Fred S. Sarfo, Stephanie Kliethermes, Dorcas Owusu,
Kenrad Nelson, Lara Dugas, Amy Luke, David Shoham, Joseph C. Forbi,
Yury E. Khudyakov, Richard S. Cooper, The United States
ASSOCIATION OF HEPATITIS E VIRUS AND
CRYOGLOBULINEMIA
Sven Pischke*, Susanne Polywka, Jan H. Schirmer, Friedrich Haag,
Martina Sterneck, Marc Luetgehetmann, Christoph Iking-Konert,
Werner Dammermann, Stefan Lueth, Frank Moosig, Ansgar W. Lohse,
Germany
THE ROLE OF GENOTYPE, PRE-CORE, BASAL CORE
PROMOTER AND PRE-S MUTATIONS OF HBV IN PATIENTS
OF HEPATOCELLULAR CARCINOMA WITH HEPATITIS C
AND OCCULT HEPATITIS B
Wei-Lun Tsai*, Jin-Shiung Cheng, Kwok-Hung Lai, Hoi-Hung Chan,
Ping-I shu, Taiwan
Vienna, Austria • April 22–26, 2015 221
P0593 CHOLESTASIS INDICATORS OF VIRAL HEPATITIS
P0594 PATIENTS
P0595 Jun Cheng*, Jiangbin Wang, Wenhong Zhang, Xingxiang Yang,
P0596 Yang Cao, China
P0597
PREDICTIVE MODEL OF HBSAG NEGATIVIZATION
IN INACTIVE HBSAG CHRONIC CARRIERS, MAINLY
CAUCASIAN
M. Luisa González-Diéguez*, Carmen A. Navascués, Gino Albines,
Mercedes Rodríguez, Valle Cadahía, María Varela, Ramón Pérez,
Manuel Rodríguez, Spain
CAN SERUM LEVEL OF HEPATITIS B SURFACE ANTIGEN
(HBSAG) DIFFERENTIATE HBSAG INACTIVE CARRIER
STATE FROM CHRONIC HEPATITIS B?
Maryam Keshvari*, Shahnaz Sali, Heidar Sharafi, Seyede Hoda Alavian,
Seyed Moayed Alavian, Faranak Etesam, Shima Salimi,
Muayad A. Merza, Iran
HIGH FREQUENCY OF ACTIVE HCV INFECTION AMONG
SEROPOSITIVES IN WEST AFRICA AND EVIDENCE FOR
MULTIPLE TRANSMISSION PATHWAYS
Jennifer Layden, Nallely Mora*, Rhichard O. Phillips, Shirley Owusi-
Ofori, Fred S. Sarfo, Stephanie Kliethermes, Dorcas Owusu,
Kenrad Nelson, Lara Dugas, Amy Luke, David Shoham, Joseph C. Forbi,
Yury E. Khudyakov, Richard S. Cooper, The United States
ASSOCIATION OF HEPATITIS E VIRUS AND
CRYOGLOBULINEMIA
Sven Pischke*, Susanne Polywka, Jan H. Schirmer, Friedrich Haag,
Martina Sterneck, Marc Luetgehetmann, Christoph Iking-Konert,
Werner Dammermann, Stefan Lueth, Frank Moosig, Ansgar W. Lohse,
Germany
THE ROLE OF GENOTYPE, PRE-CORE, BASAL CORE
PROMOTER AND PRE-S MUTATIONS OF HBV IN PATIENTS
OF HEPATOCELLULAR CARCINOMA WITH HEPATITIS C
AND OCCULT HEPATITIS B
Wei-Lun Tsai*, Jin-Shiung Cheng, Kwok-Hung Lai, Hoi-Hung Chan,
Ping-I shu, Taiwan
Vienna, Austria • April 22–26, 2015 221
